Vickram Ramkumar

Publications

• Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection
  Frontiers in Cellular Neuroscience. 2017  |   Pubmed ID: 29163050
• Epigallocatechin-3-gallate, a Prototypic Chemopreventative Agent for Protection Against Cisplatin-based Ototoxicity
  Cell Death & Disease. Jul, 2017  |   Pubmed ID: 28703809
• Tonic Suppression of PCAT29 by the IL-6 Signaling Pathway in Prostate Cancer: Reversal by Resveratrol
  PloS One. 2017  |   Pubmed ID: 28467474
• Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea
  The Journal of Neuroscience : the Official Journal of the Society for Neuroscience. Apr, 2016  |   Pubmed ID: 27053204
• Early Investigational Drugs for Hearing Loss
  Expert Opinion on Investigational Drugs. Feb, 2015  |   Pubmed ID: 25243609
• TRPV1: A Potential Drug Target for Treating Various Diseases
  Cells. May, 2014  |   Pubmed ID: 24861977
• Adenosine Receptors: Expression, Function and Regulation
  International Journal of Molecular Sciences. Jan, 2014  |   Pubmed ID: 24477263
• Essential Role of NADPH Oxidase-Dependent Reactive Oxygen Species Generation in Regulating MicroRNA-21 Expression and Function in Prostate Cancer
  Antioxidants & Redox Signaling. Jul, 2013  |   Pubmed ID: 23682737
• Resveratrol Reduces Prostate Cancer Growth and Metastasis by Inhibiting the Akt/MicroRNA-21 Pathway
  PloS One. 2012  |   Pubmed ID: 23272133
• The Design and Screening of Drugs to Prevent Acquired Sensorineural Hearing Loss
  Expert Opinion on Drug Discovery. May, 2011  |   Pubmed ID: 22646075
• Nuclear Factor κB and Adenosine Receptors: Biochemical and Behavioral Profiling
  Current Neuropharmacology. Jun, 2011  |   Pubmed ID: 22131942
• Lack of Association of a Spontaneous Mutation of the Chrm2 Gene with Behavioral and Physiologic Phenotypic Differences in Inbred Mice
  Comparative Medicine. Aug, 2010  |   Pubmed ID: 20819376
• Transtympanic Administration of Short Interfering (si)RNA for the NOX3 Isoform of NADPH Oxidase Protects Against Cisplatin-induced Hearing Loss in the Rat
  Antioxidants & Redox Signaling. Sep, 2010  |   Pubmed ID: 20214492
• Role of Beta-arrestin1/ERK MAP Kinase Pathway in Regulating Adenosine A1 Receptor Desensitization and Recovery
  American Journal of Physiology. Cell Physiology. Jan, 2010  |   Pubmed ID: 19828838
• Adenosine A(3) Receptor Suppresses Prostate Cancer Metastasis by Inhibiting NADPH Oxidase Activity
  Neoplasia (New York, N.Y.). Nov, 2009  |   Pubmed ID: 19881949
• Cisplatin Ototoxicity and Protection: Clinical and Experimental Studies
  The Tohoku Journal of Experimental Medicine. Nov, 2009  |   Pubmed ID: 19851045
• Short Interfering RNA Against Transient Receptor Potential Vanilloid 1 Attenuates Cisplatin-induced Hearing Loss in the Rat
  The Journal of Neuroscience : the Official Journal of the Society for Neuroscience. Dec, 2008  |   Pubmed ID: 19052196
• Adenosine and Dopamine Receptor Interactions in Striatum and Caffeine-induced Behavioral Activation
  Comparative Medicine. Dec, 2007  |   Pubmed ID: 18246865
• Expression of Striatal Adenosine and Dopamine Receptors in Mice Deficient in the P50 Subunit of NF-kappaB
  Life Sciences. Sep, 2007  |   Pubmed ID: 17869311
• Activation of the Adenosine A1 Receptor Inhibits HIV-1 Tat-induced Apoptosis by Reducing Nuclear Factor-kappaB Activation and Inducible Nitric-oxide Synthase
  Molecular Pharmacology. Oct, 2007  |   Pubmed ID: 17609415
• Nitric Oxide Serves As an Endogenous Regulator of Neuronal Adenosine A1 Receptor Expression
  Journal of Neurochemistry. Oct, 2006  |   Pubmed ID: 16987234
• Induction of Adenosine A1 Receptor Expression by Pertussis Toxin Via an Adenosine 5'-diphosphate Ribosylation-independent Pathway
  The Journal of Pharmacology and Experimental Therapeutics. Apr, 2006  |   Pubmed ID: 16322354
• Activation of the Adenosine A3 Receptor in RAW 264.7 Cells Inhibits Lipopolysaccharide-stimulated Tumor Necrosis Factor-alpha Release by Reducing Calcium-dependent Activation of Nuclear Factor-kappaB and Extracellular Signal-regulated Kinase 1/2
  The Journal of Pharmacology and Experimental Therapeutics. Jan, 2006  |   Pubmed ID: 16188954
• Essential Role of Rac1/NADPH Oxidase in Nerve Growth Factor Induction of TRPV1 Expression
  Journal of Neurochemistry. Dec, 2005  |   Pubmed ID: 16283857
• Osmotic Diuretics Induce Adenosine A1 Receptor Expression and Protect Renal Proximal Tubular Epithelial Cells Against Cisplatin-mediated Apoptosis
  The Journal of Biological Chemistry. Oct, 2004  |   Pubmed ID: 15272017
• Protection Against Cisplatin Ototoxicity by Adenosine Agonists
  Biochemical Pharmacology. May, 2004  |   Pubmed ID: 15081879
• Direct Interaction of Adenosine with the TRPV1 Channel Protein
  The Journal of Neuroscience : the Official Journal of the Society for Neuroscience. Apr, 2004  |   Pubmed ID: 15071115
• Noise Induces A1 Adenosine Receptor Expression in the Chinchilla Cochlea
  Hearing Research. Feb, 2004  |   Pubmed ID: 14759570
• Hypertonicity Inhibits Lipopolysaccharide-induced Nitric Oxide Synthase Expression in Smooth Muscle Cells by Inhibiting Nuclear Factor KappaB
  Molecular Pharmacology. Jun, 2003  |   Pubmed ID: 12761333
• Hsp70 in the Inferior Colliculus of Fischer-344 Rats: Effects of Age and Acoustic Stress
  Hearing Research. Aug, 2002  |   Pubmed ID: 12208549
• Cisplatin Up-regulates the Adenosine A(1) Receptor in the Rat Kidney
  European Journal of Pharmacology. May, 2002  |   Pubmed ID: 12065079
• Adenosine, Oxidative Stress and Cytoprotection
  Japanese Journal of Pharmacology. Jul, 2001  |   Pubmed ID: 11488425